Download Medical Notes on Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations Medical Notes

About This Presentation

Description:This report titled, “Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations” is by the IQVIA Institute and is an analysis of the orphan drug market. The report explores this topic of orphan drugs’ orphan and non-orphan indication approvals and their associated patent and market exclusivities. The report also examines orphan drug pricing relative to patient numbers, how those prices change over time, and – in a first-of-its-kind comprehensive analysis – compares current disease epidemiology to the number of treated patients to demonstrate the challenges in bringing orphan drugs to patients even after they are approved.

Tags:Healthcare, Orphan Drugs, United States, market, pricing, disease epidemiology

Published on: Jul 20, 2020 | Views : 1582 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Data exclusivity, market protection, orphan and paediatric rewards

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

Data exclusivity, market protection, orphan and paediatric rewards

REJUVENATION MEDICINE

The Impact of COVID-19 on Cancer Treatment in Italy

Understanding Medicine Spending in Australia - Trends and dynamics in healthcare and medicine spending

The Impact of COVID-19 on Cancer Treatment - EU5 Report

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

Understanding Neuromuscular Disease Care Current State and Future Prospects

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

2020 US and global life sciences outlook

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

HEALTH A TO Z